Community/Retail

Trastuzumab is indicated for the treatment of human epidermal growth factor receptor-2 (HER2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Cases of SJS have been in the news lately. Here is what to know.

In late 2018, Pharmacy Times surveyed readers to determine their satisfaction levels with their jobs and salaries as pharmacists.

Vaccine misinformation is part of the growing problem that is creating a public health crisis, especially surrounding the global measles outbreak.

Dupilumab is now the first biologic therapy approved for the patient population.

There has been mixed evidence regarding whether there is an association between hormone replacement therapy (HRT) and Alzheimer disease.

What is causing the mysterious pain in this man's leg?

With this approval, atezolizumab plus nab-paclitaxel is the first cancer immunotherapy regimen to be approved for breast cancer.

Dupilumab (Dupixent, Regeneron and Sanofi) would be the first FDA-approved biologic for the treatment of severe chronic rhinosinusitis with nasal polyps.

Hello and welcome to the Pharmacy Times News Network. I’m Nicole Grassano your host for our Pharmacy Week in Review.

Recently approved by the US Food and Drug Administration (FDA), the Biktarvyregimen is indicated for the treatment of adults with HIV-1 who have no history of antiretroviral therapy.

An individual treated for HIV is believed to be in long-term remission, according to experts in the United Kingdom. 'The London Patient’ is only the second documented case of sustained remission for HIV infection.

Venetoclax (Venclexta) plus obinutuzumab (Gazyva) is being developed for patients with previously-untreated chronic lymphocytic leukemia and co-existing medical conditions.

The awards will be presented at the ASHP’s Summer Meetings and the 54th Midyear Clinical Meeting.

The sNDA is based on results from the phase 3 CAPSTONE-2 study of a single dose of Xofluza compared with placebo or oseltamivir 75 mg, twice daily for 5 days, in people 12 years of age or older who are at high risk of complications from the flu.

The Priority Review is set to fast-track an application of a drug that may potentially represent a significant advancement in treatment for a serious condition.

Once Spravato is determined as an appropriate treatment option, in accordance with the REMS, the patient will be treated at a certified treatment center that is trained to administer the medicine and address patient needs.

FDA Commissioner Scott Gottlieb, MD, cited that he was “missing” his family as the reason for his impending departure.

The CDC urges health care providers to implement its recommendations and to regularly review their facility infection data, among other intervention methods.

Expert witnesses all testified that there is no evidence to support the belief by some parents that vaccines cause autism.

In a statement, the group said it conducted a half-year investigation into pharmacies dispensing prescriptions to the wrong people, and has found that a significant enough problem exists nationwide to warrant the action.

Semaglutide offers a non-insulin solution that, in combination with healthy diet and exercise, may improve blood sugar.

In one example cited in the paper, officials with Ochsner Health System reported using their online patient portal to help treat hypertension with a novel digital medicine program that combined patient-reported blood pressure data, clinical data, and coaching.

How voice assistants are becoming more important in health care.

Students who complete a PTCB-recognized education/training program will be eligible to apply for, and earn, their CPhT credential starting in 2020.

Feel More Like You was developed in collaboration with Look Good, Feel Better Foundation, the leading cancer support organization focusing attention on the appearance and beauty needs of cancer patients, and Cancer Support Community, the largest professionally led, nonprofit network of cancer support worldwide.